MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.780
+0.050 (2.89%)
Jul 10, 2026, 4:00 PM EDT - Market closed
MetaVia Market Cap
MetaVia has a market cap or net worth of $9.19 million as of July 10, 2026. Its market cap has decreased by -30.92% in one year.
Market Cap
9.19M
Enterprise Value
-4.35M
1-Year Change
-30.92%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $9.19M, a decrease of -99.99%. That is a compound annual growth rate of -76.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 9.19M | -50.41% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 9.75M |
| Curis | 9.67M |
| Quoin Pharmaceuticals | 9.38M |
| TransCode Therapeutics | 9.12M |
| Aprea Therapeutics | 9.01M |
| BioRestorative Therapies | 8.78M |
| Cadrenal Therapeutics | 8.63M |
| Jupiter Neurosciences | 8.51M |